The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study (original) (raw)

Abstract

sparkles

AI

Depressive symptoms in patients with schizophrenia are common, ranging significantly in reported prevalence. This study investigates prescribing patterns of antidepressants concerning depressive symptoms over a one-year period. Findings indicate that the percentage of patients receiving antidepressants correlates with the presence of depressive symptoms, with significant differences noted in both treatment and symptom trajectories. The study highlights the challenge of managing depressive symptoms in schizophrenia and the implications for clinical practices involving antidepressant use.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (47)

  1. Addington D, Addington J, Atkinson M. A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Schizophr Res 1996;19:205-12.
  2. Addington D, Addington J, Patten S, Remington G, Moamai J, Labelle A, et al. Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizo- phrenia. J Clin Psychopharmacol 2002;22(1):20-5.
  3. American Psychiatric Association. In: Practice guideline for the treatment of patients with schizophrenia2nd ed, United States of America: Arlington; 2004.
  4. An Der Heiden W, Konnecke R, Maurer K, Ropeter D, Hafner H. Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2005;255:174-84.
  5. An FR, Xiang YT, Wang CY, Zhang GP, Chiu HF, Chan SS, et al. Change of psychotropic drug prescription for schizophrenia in a psychiatric institution in Beijing, China between 1999 and 2008. Int J Clin Pharmacol Ther Toxicol 2010;48:270-4.
  6. Angermeyer MC, Kuhn L, Goldstein JM. Gender and the course of schizophre- nia: differences in treated outcomes. Schizophr Bull 1990;16:293-307.
  7. Bartels SJ, Drake RE. Depressive symptoms in schizophrenia: comprehensive differential diagnosis. Compr Psychiatry 1988;29:467-83.
  8. Baynes D, Mulholland C, Cooper SJ, Montgomery RC, MacFlynn G, Lynch G, et al. Depressive symptoms in stable chronic schizophrenia: prevalence and relation- ship to psychopathology and treatment. Schizophr Res 2000;45:47-56.
  9. Birchwood M, Mason R, MacMillan F, Healy J. Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychol Med 1993;23(2):387-95.
  10. Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull 2008;35(2):383-402.
  11. Carpenter WT, Strauss JS. The prediction of outcome in schizophrenia. IV: eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991;179:517-25.
  12. Conley RR, Ascher-Svanum H, Zhu B, Faries DE, Kinon BJ. The burden of depressive symptoms in the long-term treatment of patients with schizophre- nia. Schizophr Res 2007;90:186-97.
  13. DSM-IV -Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC, United States of America: American Psychiatric Association; 1994.
  14. Duisterwinkel G, Bosker FJ, Scholte-Stalenhoef AN, Vervoort M, Knegtering H. Antipsychotic augmentation strategies to ameliorate negative and cognitive symptoms in schizophrenia; implications for future research. Cent Nerv Syst Agents Med Chem 2008;8:10-25.
  15. Freudenreich O, Tranulis C, Cather C, Henderson DC, Evins AE, Goff DC. Depressive symptoms in schizophrenia outpatients -Prevalence and clinical correlates. Clin Schizophr Relat Psychoses 2008;2(2):127-35.
  16. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361:653-61.
  17. Ha ¨fner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003;28(2):17-54.
  18. Harrow M, Yonan CA, Sands JR, Marengo J. Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved? Schizophr Bull 1994;20:327- 38.
  19. Hirsch SR, Jolley AG, Barnes TR, Liddle PF, Curson DA, Patel A, et al. Dysphoric and depressive symptoms in chronic schizophrenia. Schizophr Res 1989;2:259-64.
  20. Johnson DA. Studies of depressive symptoms in schizophrenia. Br J Psychiatry 1981;139:89-101.
  21. Kaymaz N, Van Os J, Loonen AJ, Nolen WA. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 2008;69:1423-36.
  22. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008;5(2):260-8.
  23. Koreen AR, Siris SG, Chakos M, Alvir J, Mayerhoff D, Lieberman J. Depression in first-episode schizophrenia. Am J Psychiatry 1993;150:1643-8.
  24. Kulhara P, Avasthi A, Chadda R, Chandiramani K, Mattoo SK, Kota SK, et al. Negative and depressive symptoms in schizophrenia. Br J Psychiatry 1989;154:207-11.
  25. Lam RW, Peters R, Sladen-Dew N, Altman S. A community-based clinic survey of antidepressant use in persons with schizophrenia. Can J Psychiatry 1998;43:513-6.
  26. Leff J, Tress K, Edwards B. The clinical course of depressive symptoms in schizophrenia. Schizophr Res 1988;1:25-30.
  27. Lindenmayer JP, Kay SR. Depression, affect and negative symptoms in schizo- phrenia. Br J Psychiatry 1989;11(7):108-14.
  28. Micallef J, Fakra E, Blin O. Use of antidepressant drugs in schizophrenic patients with depression. Encephale 2006;32:263-9.
  29. Mickey J, Greenland S. A study of the impact of confounder-selection criteria on effect estimation. Am J Epidemiol 1989;128:125-37.
  30. Mo ¨ller HJ. Drug treatment of depressive symptoms in schizophrenia. Clin Schizophr Relat Psychoses 2008;1(4):328-40.
  31. Mu ¨ller MJ. Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia. Prog Neurpsychopharmacol Biol Psychiatry 2007;31:1095-100.
  32. National Institute for Clinical Excellence (NICE). National clinical practice guideline for schizophrenia. United Kingdom; 2008.
  33. Plasky P. Antidepressants usage in schizophrenia. Schizophr Bull 1991;17(4): 649-57.
  34. Restifo K, Harkavy-Friedman JM, Shrout PE. Suicidal behavior in schizophre- nia: a test of the demoralization hypothesis. J Nerv Ment Dis 2009;197:147- 53.
  35. Ritsner M, Kurs R, Gibel A, Hirschmann S, Shinkarenko E, Ratner Y. Predictors of quality of life in major psychoses: a naturalistic follow-up study. J Clin Psychiatry 2003;64:308-15.
  36. Rittmannsberger H, Meise U, Schauflinger K, Horvath E, Donat H, Hinterhuber H. Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics. Eur Psychiatry 1999;14:33-40.
  37. Rocca P, Bellino S, Calvarese P, Marchiaro L, Patria L, Rasetti R, et al. Depressive and negative symptoms in schizophrenia: different effects on clinical features. Compr Psychiatry 2005;46(4):304-10.
  38. Rummel C, KisslingW, Leucht S. Antidepressants for the negative symptoms of schizophrenia. Cochrane Database Syst Rev 2006;3:CD005581.
  39. Sands JR, Harrow M. Depression during the longitudinal course of schizophre- nia. Schizophr Bull 1999;25:157-71.
  40. Schorr SG, Slooff CJ, Bruggeman R, Taxis K. Prevalence of metabolic syndrome in patients with psychotic disorders in the Netherlands. J Clin Psychophar- macol 2009;29(4):399-402.
  41. Schorr SG, Slooff CJ, Bruggeman R, Taxis K. The incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one year. J Psychiatric Res 2009;43(13):1106-11.
  42. Sepehry AA, Potvin S, Elie R, Stip E. Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta- analysis. J Clin Psychiatry 2007;68:604-10.
  43. Siris SG, Adan F, Cohen M, Mandeli J, Aronson A, Casey E. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. Am J Psychiatry 1988;12(145):1532-7.
  44. Siris SG, Bench C. Depression and schizophrenia. In: Hirsch S, Weinberger D, editors. Schizophrenia. 2nd ed, Oxford, UK: Blackwell; 2003. p. 140-67.
  45. Trimbos-Institute. Multidisciplinary Guideline on Schizophrenia. Utrecht, The Netherlands; 2010.
  46. Van Putten T, May RP. ''Akinetic depression'' in schizophrenia. Arch Gen Psychiatry 1978;35:1101-7.
  47. Whitehead C, Moss S, Cardno A, Lewis G. Antidepressants for people with both schizophrenia and depression. Cochrane Database Syst Rev 2002;2(CD002305): 1469-93.